Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Sonova Holding AG is a Swiss-based global leader in innovative hearing care solutions, specializing in hearing aids, cochlear implants, personal audio devices, wireless communication systems, and audiological care services. Founded in 1947 and headquartered in Stäfa, Switzerland, the company operates through four key business segments: Hearing Instruments, Audiological Care, Consumer Hearing, and Cochlear Implants. Its portfolio includes behind-the-ear, receiver-in-canal, and custom in-the-ear hearing instruments, hearing protection products, FM systems, and miniaturized wireless accessories. Sonova markets these under prominent brands such as Phonak, Unitron, AudioNova, Advanced Bionics, and Sennheiser (under license), alongside regional brands. With over 18,000 employees, more than 1,800 patents, and presence in over 100 countries via subsidiaries in 30+ nations and independent distributors, Sonova generated CHF 3.9 billion in sales for the 2024/25 financial year. Recognized as Europe's 12th most innovative company in 2025 by Fortune and Statista, it plays a pivotal role in advancing hearing health technology worldwide, serving adults and children with hearing loss across diverse markets.
18.74% operating margin is respectable but not wide. ROIC at 13.08%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue declined 0.2% YoY. The question is whether this is cyclical or a structural shift.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
CHF 3.61B
▼ -0.2% YoY
Net Income (TTM)
CHF 440M
▼ -19.7% YoY
Op. Margin
18.74%
▼ -1.2pp YoY
ROIC
13.08%
▼ -0.5pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
CHF 632M
▼ -4.1% YoY
Op. Cash Flow (TTM)
CHF 685M
▼ -7.5% YoY
Net Debt
CHF 990M
Cash & Equiv.
CHF 722M
3Y CAGR: -1.2%
3Y CAGR: +0.1%
Continue Research